{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T02:27:40Z","timestamp":1791080860548,"version":"4.1.0"},"reference-count":87,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1979,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1111\/j.1478-3231.2009.02193.x","type":"journal-article","created":{"date-parts":[[2010,1,7]],"date-time":"2010-01-07T16:04:43Z","timestamp":1262880283000},"page":"502-511","source":"Crossref","is-referenced-by-count":38,"title":["Occult hepatitis C virus infection: what does it mean?"],"prefix":"10.1111","volume":"30","author":[{"given":"Tram N. Q.","family":"Pham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla S.","family":"Coffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz I.","family":"Michalak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","reference":[{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB1","doi-asserted-by":"crossref","unstructured":"1.\u2002 Alberti A , Chemello L , Benvegnu L. Natural history of hepatitis C. J Hepatol 1999; 31: 17-24.","DOI":"10.1016\/S0168-8278(99)80369-9"},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB2","doi-asserted-by":"crossref","unstructured":"2.\u2002 Fried MW , Shiffman ML , Reddy KR , et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002; 347: 975-82.","DOI":"10.1056\/NEJMoa020047"},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB3","doi-asserted-by":"crossref","unstructured":"3.\u2002 Seeff LB , Hoofnagle JH. National Institutes of Health Consensus Development Conference: Management of Hepatitis C: 2002. Hepatology 2002; 36: S1-2.","DOI":"10.1053\/jhep.2002.36992"},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB4","unstructured":"4.\u2002 Varghese R , Al Khaldi J , Asker H , et al. Treatment of chronic hepatitis C genotype 4 with peginterferon alpha-2a plus ribavirin. Hepatogastroenterology 2009; 56: 218-22."},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB5","unstructured":"5.\u2002 Zignego AL , Ferri C , Monti M , et al. Hepatitis C virus as a lymphotropic agent: evidence and pathogenetic implications. Clin Exp Rheumatol 1995; 13: S33-7."},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB6","doi-asserted-by":"crossref","unstructured":"6.\u2002 Roque-Alfonso AM , Ducoulombier D , Di Liberto G , et al. Compartmentalization of hepatitis C virus genotypes between plasma and peripheral blood mononuclear cells. J Virol 2005; 79: 6349-57.","DOI":"10.1128\/JVI.79.10.6349-6357.2005"},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB7","doi-asserted-by":"crossref","unstructured":"7.\u2002 Pal S , Sulivan DG , Kim S , et al. Productive replication of hepatitis C virus in perihepatic lymph nodes in vivo: implications of HCV lymphotropism. Gastroeneterology 2006; 130: 1107-16.","DOI":"10.1053\/j.gastro.2005.12.039"},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB8","doi-asserted-by":"crossref","unstructured":"8.\u2002 Zignego AL , Giannini C , Monti M , Gragnani L. Hepatitis C virus lymphotropism: lessons from a decade of studies. Dig Liver Dis 2007; 39: S38-45.","DOI":"10.1016\/S1590-8658(07)80009-0"},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB9","doi-asserted-by":"crossref","unstructured":"9.\u2002 Blackard JT , Kemmer N , Sherman KE. Extrahepatic replication of HCV: insights into clinical manifestations and biological consequences. Hepatology 2006; 44: 15-22.","DOI":"10.1002\/hep.21283"},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB10","doi-asserted-by":"crossref","unstructured":"10.\u2002 Pham TNQ , Michalak TI. Occult persistence and lymphotropism of hepatitis C virus infection. World J Gastroenterol 2008; 14: 2789-93.","DOI":"10.3748\/wjg.14.2789"},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB11","doi-asserted-by":"crossref","unstructured":"11.\u2002 Pham TNQ , Mercer SE , Michalak TI. Chronic hepatitis C and persistent occult hepatitis C virus infection are characterized by distinct immune cell cytokine expression profiles. J Viral Hepat 2009; 16: 547-56.","DOI":"10.1111\/j.1365-2893.2009.01092.x"},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB12","doi-asserted-by":"crossref","unstructured":"12.\u2002 Pham TNQ , King D , MacParland SA , et al. Hepatitis C virus replicates in the same immune cell subsets in chronic hepatitis C and occult infection. Gastroenterology 2008; 134: 812-22.","DOI":"10.1053\/j.gastro.2007.12.011"},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB13","doi-asserted-by":"crossref","unstructured":"13.\u2002 Ducoulombier D , Roque-Afonso AM , Di Liberto G , et al. Frequent compartmentalization of hepatitis C virus variants in circulating B cells and monocytes. Hepatology 2004; 39: 817-25.","DOI":"10.1002\/hep.20087"},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB14","doi-asserted-by":"crossref","unstructured":"14.\u2002 MacParland SA , Pham TN , Gujar SA , Michalak TI. De novo infection and propagation of wild-type hepatitis C virus in human T lymphocytes in vitro. J Gen Virol 2006; 87: 3577-86.","DOI":"10.1099\/vir.0.81868-0"},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB15","doi-asserted-by":"crossref","unstructured":"15.\u2002 Kondo Y , Sung VM , Machida K , Liu M , Lai MM. Hepatitis C virus infects T cells and affects interferon-gamma signaling in T cell lines. Virology 2007; 361: 161-73.","DOI":"10.1016\/j.virol.2006.11.009"},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB16","doi-asserted-by":"crossref","unstructured":"16.\u2002 Di Liberto G , Roque-Afonso AM , Kara R , et al. Clinical and therapeutic implications of hepatitis C virus compartmentalization. Gastroenterology 2006; 131: 76-84.","DOI":"10.1053\/j.gastro.2006.04.016"},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB17","doi-asserted-by":"crossref","unstructured":"17.\u2002 Navas S , Martin J , Quiroga JA , et al. Genetic diversity and tissue compartmentalization of the hepatitis C virus genome in blood mononuclear cells, liver, and serum from chronic hepatitis C patients. J Virol 1998; 72: 1640-6.","DOI":"10.1016\/S0168-8278(98)80595-3"},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB18","doi-asserted-by":"crossref","unstructured":"18.\u2002 Roque-Afonso AM , Ducoulombier D , Di Liberto G , et al. Compartmentalization of hepatitis C virus genotypes between plasma and peripheral blood mononuclear cells. J Virol 2005; 79: 6349-57.","DOI":"10.1128\/JVI.79.10.6349-6357.2005"},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB19","doi-asserted-by":"crossref","unstructured":"19.\u2002 Forton DM , Karayiannis P , Mahmud N , et al. Identification of unique hepatitis C virus quasispecies in the central nervous system and comparative analysis of internal translational efficiency of brain, liver, and serum variants. J Virol 2004; 78: 5170-83.","DOI":"10.1128\/JVI.78.10.5170-5183.2004"},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB20","doi-asserted-by":"crossref","unstructured":"20.\u2002 Laporte J , Bain C , Maurel P , et al. Differential distribution and internal translation efficiency of hepatitis C virus quasispecies present in dendritic and liver cells. Blood 2003; 101: 52-7.","DOI":"10.1182\/blood-2002-03-0818"},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB21","doi-asserted-by":"crossref","unstructured":"21.\u2002 Zignego AL , Ferri C , Giannini C , et al. Hepatitis C virus infection in mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma: evidence for a pathogenetic role. Arch Virol 1997; 142: 545-55.","DOI":"10.1007\/s007050050100"},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB22","doi-asserted-by":"crossref","unstructured":"22.\u2002 Ferri C , Monti M , LaCivita L , et al. Infection of peripheral blood mononuclear cells by hepatitis C virus in mixed cryoglobulinemia. Blood 1993; 82: 3701-4.","DOI":"10.1182\/blood.V82.12.3701.3701"},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB23","doi-asserted-by":"crossref","unstructured":"23.\u2002 Mizorogi F , Hiramoto J , Nozato A , et al. Hepatitis C virus infection in patients with B cell non-Hodgkin's lymphoma. Intern Med 2000; 39: 112-7.","DOI":"10.2169\/internalmedicine.39.112"},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB24","doi-asserted-by":"crossref","unstructured":"24.\u2002 Martyak LA , Yeganeh M , Saab S. Hepatitis C and lymphoproliferative disorders: from mixed cryoglobulinemia to non-Hodgkin's lymphoma. Clin Gastroenterol Hepatol 2009; 7: 900-5.","DOI":"10.1016\/j.cgh.2009.03.035"},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB25","doi-asserted-by":"crossref","unstructured":"25.\u2002 Pham TNQ , MacParland SA , Mulrooney PM , et al. Hepatitis C virus persistence after spontaneous or treatment-induced resolution of hepatitis C. J Virol 2004; 78: 5867-74.","DOI":"10.1128\/JVI.78.11.5867-5874.2004"},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB26","doi-asserted-by":"crossref","unstructured":"26.\u2002 Radkowski M , Gallegos-Orozco JF , Jablonska J , et al. Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C. Hepatology 2005; 41: 106-14.","DOI":"10.1002\/hep.20518"},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB27","doi-asserted-by":"crossref","unstructured":"27.\u2002 Castillo I , Rodriguez-Inigo E , Lopez-Alcorocho JM , et al. Hepatitis C virus replicates in the liver of patients who have a sustained response to antiviral treatment. Clin Infect Dis 2006; 43: 1277-83.","DOI":"10.1086\/508198"},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB28","unstructured":"28.\u2002 Ciancio A , Smedile A , Giordanino C , et al. Long-term follow-up of previous hepatitis C virus positive nonresponders to interferon monotherapy successfully retreated with combination therapy: are they really cured? Am J Gastroenterol 2006; 101: 1811-6."},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB29","doi-asserted-by":"crossref","unstructured":"29.\u2002 Pham TNQ , Mulrooney-Cousins PM , Mercer SE , et al. Antagonistic expression of hepatitis C virus and alpha interferon in lymphoid cells during persistent occult infection. J Viral Hepat 2007; 14: 537-48.","DOI":"10.1111\/j.1365-2893.2006.00834.x"},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB30","doi-asserted-by":"crossref","unstructured":"30.\u2002 Castillo I , Pardo M , Bartolome J , et al. Occult hepatitis C virus infection in patients in whom the etiology of persistently abnormal results of liver-function tests is unknown. J Infect Dis 2004; 189: 7-14.","DOI":"10.1086\/380202"},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB31","doi-asserted-by":"crossref","unstructured":"31.\u2002 Gallegos-Orozco JF , Rakela J , et al. Persistence of hepatitis C virus in peripheral blood mononuclear cells of sustained viral responders to pegylated interferon and ribavirin therapy. Dig Dis Sci 2008; 53: 2564-8.","DOI":"10.1007\/s10620-008-0323-x"},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB32","doi-asserted-by":"crossref","unstructured":"32.\u2002 Hoare M , Gelson WT , Rushbrook SM , et al. Histological changes in HCV antibody-positive, HCV RNA-negative subjects suggest persistent virus infection. Hepatology 2008; 48: 1737-45.","DOI":"10.1002\/hep.22484"},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB33","doi-asserted-by":"crossref","unstructured":"33.\u2002 Quiroga JA , Llorente S , Castillo I , et al. Virus-specific T-cell responses associated with hepatitis C virus (HCV) persistence in the liver after apparent recovery from HCV infection. J Med Virol 2006; 78: 1190-7.","DOI":"10.1002\/jmv.20680"},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB34","doi-asserted-by":"crossref","unstructured":"34.\u2002 Bernardin F , Tobler L , Walsh I , et al. Clearance of hepatitis C virus RNA from the peripheral blood mononuclear cells of blood donors who spontaneously or therapeutically control their plasma viremia. Hepatology 2008; 47: 1446-52.","DOI":"10.1002\/hep.22184"},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB35","doi-asserted-by":"crossref","unstructured":"35.\u2002 Halfon P , Bourliere M , Ouzan D , et al. Occult hepatitis C virus infection revisited with ultrasensitive real-time PCR assay. J Clin Microbiol 2008; 46: 2106-8.","DOI":"10.1128\/JCM.00345-08"},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB36","doi-asserted-by":"crossref","unstructured":"36.\u2002 Marcellin P , Boyer N , Gervais A , et al. Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy. Ann Intern Med 1997; 127: 875-81.","DOI":"10.7326\/0003-4819-127-10-199711150-00003"},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB37","unstructured":"37.\u2002 Naga S , Raghuraman SHT , Liang JRB. Minute levels of HCV RNA persist for an extended period of time after clinical recovery from hepatitis C but are ultimately cleared 15th International Symposium on Hepatitis C Virus and Related Viruses 2008: 66."},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB38","doi-asserted-by":"crossref","unstructured":"38.\u2002 Maylin S , Martinot-Peignoux M , Moucari R , et al. Eradication of hepatitis C virus in patients successfully treated for chronic hepatitis C. Gastroenterology 2008; 135: 821-9.","DOI":"10.1053\/j.gastro.2008.05.044"},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB39","doi-asserted-by":"crossref","unstructured":"39.\u2002 George SL , Bacon BR , Brunt EM , et al. Clinical, virologic, histologic, and biochemical outcomes after successful HCV therapy: a 5-year follow-up of 150 patients. Hepatology 2009; 49: 729-38.","DOI":"10.1002\/hep.22694"},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB40","unstructured":"40.\u2002 Carreno V , Bartolome J , Castillo I , Quiroga JA. Does occult hepatitis C virus infection exist? J Clin Microbiol 2008; 46: 3550-2."},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB41","doi-asserted-by":"crossref","unstructured":"41.\u2002 Pham TNQ , Michalak TI. Factors influencing detection of low levels of hepatitis C virus (HCV) genome and its replication. J Hepatol 2009; 50: S129.","DOI":"10.1016\/S0168-8278(09)60337-8"},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB42","doi-asserted-by":"crossref","unstructured":"42.\u2002 Pham TNQ , Michalak TI. Hepatitis C virus in peripheral blood mononuclear cells of individuals with isolated anti-hepatitis C virus antibody reactivity. Hepatology 2008; 48: 350-1.","DOI":"10.1002\/hep.22384"},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB43","doi-asserted-by":"crossref","unstructured":"43.\u2002 Germer JJ , Zein NN. Advances in the molecular diagnosis of hepatitis C and their clinical implications. Mayo Clin Proc 2001; 76: 911-20.","DOI":"10.1016\/S0025-6196(11)62111-3"},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB44","doi-asserted-by":"crossref","unstructured":"44.\u2002 Pham TNQ , MacParland SA , Coffin CS , et al. Mitogen-induced upregulation of hepatitis C virus expression in human lymphoid cells. J Gen Virol 2005; 86: 657-66.","DOI":"10.1099\/vir.0.80624-0"},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB45","doi-asserted-by":"crossref","unstructured":"45.\u2002 Frenkel N , Schirmer EC , Katsafanas G , June CH. T-cell activation is required for efficient replication of human herpesvirus 6. J Virol 1990; 64: 4598-602.","DOI":"10.1128\/JVI.64.9.4598-4602.1990"},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB46","doi-asserted-by":"crossref","unstructured":"46.\u2002 Gowda SD , Stein BS , Mohagheghpour N , et al. Evidence that T cell activation is required for HIV-1 entry in CD4+ lymphocytes. J Immunol 1989; 142: 773-80.","DOI":"10.4049\/jimmunol.142.3.773"},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB47","doi-asserted-by":"crossref","unstructured":"47.\u2002 Hyypia T , Korkiamaki P , Vainionpaa R. Replication of measles virus in human lymphocytes. J Exp Med 1985; 161: 1261-71.","DOI":"10.1084\/jem.161.6.1261"},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB48","doi-asserted-by":"crossref","unstructured":"48.\u2002 Castillo I , Bartolome J , Quiroga JA , et al. Presence of HCV-RNA after ultracentrifugation of serum samples during the follow-up of chronic hepatitis C patients with a sustained virological response may predict reactivation of hepatitis C virus infection. Aliment Pharmacol Ther 2009; 30: 477-86.","DOI":"10.1111\/j.1365-2036.2009.04066.x"},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB49","doi-asserted-by":"crossref","unstructured":"49.\u2002 Marcellin P , Boyer N , Gervais A , et al. Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy. Ann Intern Med 1997; 127: 875-81.","DOI":"10.7326\/0003-4819-127-10-199711150-00003"},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB50","doi-asserted-by":"crossref","unstructured":"50.\u2002 Formann E , Steindl-Munda P , Hofer H , et al. Long-term follow-up of chronic hepatitis C patients with sustained virological response to various forms of interferon-based anti-viral therapy. Aliment Pharmacol Ther 2006; 23: 507-11.","DOI":"10.1111\/j.1365-2036.2006.02785.x"},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB51","doi-asserted-by":"crossref","unstructured":"51.\u2002 George SL , Bacon BR , Brunt EM , et al. Clinical, virologic, histologic, and biochemical outcomes after successful HCV therapy: a 5-year follow-up of 150 patients. Hepatology 2009; 49: 729-38.","DOI":"10.1002\/hep.22694"},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB52","doi-asserted-by":"crossref","unstructured":"52.\u2002 Reichard O , Glaumann H , Fryden A , et al. Long-term follow-up of chronic hepatitis C patients with sustained virological response to alpha-interferon. J Hepatol 1999; 30: 783-7.","DOI":"10.1016\/S0168-8278(99)80129-9"},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB53","doi-asserted-by":"crossref","unstructured":"53.\u2002 Camma C , Giunta M , Pinzello G , et al. Chronic hepatitis C and interferon alpha: conventional and cumulative meta-analyses of randomized controlled trials. Am J Gastroenterol 1999; 94: 581-95.","DOI":"10.1111\/j.1572-0241.1999.00919.x"},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB54","doi-asserted-by":"crossref","unstructured":"54.\u2002 Charlton M , Seaberg E , Wiesner R , et al. Predictors of patient and graft survival following liver transplantation for hepatitis C. Hepatology 1998; 28: 823-30.","DOI":"10.1002\/hep.510280333"},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB55","doi-asserted-by":"crossref","unstructured":"55.\u2002 Nudo CG , Cortes RA , Weppler D , et al. Effect of pretransplant hepatitis C virus RNA status on posttransplant outcome. Transplant Proc 2008; 40: 1449-55.","DOI":"10.1016\/j.transproceed.2008.03.158"},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB56","doi-asserted-by":"crossref","unstructured":"56.\u2002 Zhou S , Terrault NA , Ferrell L , et al. Severity of liver disease in liver transplantation recipients with hepatitis C virus infection: relationship to genotype and level of viremia. Hepatology 1996; 24: 1041-6.","DOI":"10.1002\/hep.510240510"},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB57","doi-asserted-by":"crossref","unstructured":"57.\u2002 Lin A , Thadareddy A , Goldstein MJ , Lake-Bakaar G. Immune suppression leading to hepatitis C virus re-emergence after sustained virological response. J Med Virol 2008; 80: 1720-2.","DOI":"10.1002\/jmv.21257"},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB58","doi-asserted-by":"crossref","unstructured":"58.\u2002 Thomopoulos K , Giannakoulas NC , Tsamandas AC , et al. Recurrence of HCV infection in a sustained responder after chemotherapy for non-Hodgkin's lymphoma: successful retreatment. Am J Med Sci 2008; 336: 73-6.","DOI":"10.1097\/MAJ.0b013e318159d1a8"},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB59","doi-asserted-by":"crossref","unstructured":"59.\u2002 Lee WM , Polson JE , Carney DS , et al. Reemergence of hepatitis C virus after 8.5 years in a patient with hypogammaglobulinemia: evidence for an occult viral reservoir. J Infect Dis 2005; 192: 1088-92.","DOI":"10.1086\/432917"},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB60","doi-asserted-by":"crossref","unstructured":"60.\u2002 Mehta SH , Cox A , Hoover DR , et al. Protection against persistence of hepatitis C. Lancet 2002; 359: 1478-83.","DOI":"10.1016\/S0140-6736(02)08435-0"},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB61","doi-asserted-by":"crossref","unstructured":"61.\u2002 Berasain C , Betes M , Panizo A , et al. Pathological and virological findings in patients with persistent hypertransaminasaemia of unknown aetiology. Gut 2000; 47: 429-35.","DOI":"10.1136\/gut.47.3.429"},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB62","doi-asserted-by":"crossref","unstructured":"62.\u2002 Veldt BJ , Saracco G , Boyer N , et al. Long term clinical outcome of chronic hepatitis C patients with sustained virological response to interferon monotherapy. Gut 2004; 53: 1504-08.","DOI":"10.1136\/gut.2003.038257"},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB63","doi-asserted-by":"crossref","unstructured":"63.\u2002 Veldt BJ , Heathcote EJ , Wedemeyer H , et al. Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis. Ann Intern Med 2007; 147: 677-84.","DOI":"10.7326\/0003-4819-147-10-200711200-00003"},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB64","doi-asserted-by":"crossref","unstructured":"64.\u2002 Makiyama A , Itoh Y , Kasahara A , et al. Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma after a sustained response to interferon therapy. Cancer 2004; 101: 1616-22.","DOI":"10.1002\/cncr.20537"},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB65","doi-asserted-by":"crossref","unstructured":"65.\u2002 Kobayashi S , Takeda T , Enomoto M , et al. Development of hepatocellular carcinoma in patients with chronic hepatitis C who had a sustained virological response to interferon therapy: a multicenter retrospective cohort study of 1124 patients. Liver Int 2007; 27: 186-91.","DOI":"10.1111\/j.1478-3231.2006.01406.x"},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB66","doi-asserted-by":"crossref","unstructured":"66.\u2002 Mashitani T , Yoshiji H , Yamazaki M , et al. Development of hepatocellular carcinoma in a patient 13 years after sustained virological response to interferon against chronic hepatitis C: a case report. Case J 2009; 2: doi:.","DOI":"10.1186\/1757-1626-2-18"},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB67","doi-asserted-by":"crossref","unstructured":"67.\u2002 Sanefuji K , Kayashima H , Iguchi T , et al. Characterization of hepatocellular carcinoma developed after achieving sustained virological response to interferon therapy for hepatitis C. J Surg Oncol 2009; 99: 32-7.","DOI":"10.1002\/jso.21176"},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB68","doi-asserted-by":"crossref","unstructured":"68.\u2002 Tsuda N , Yuki N , Mochizuki K , et al. Long-term clinical and virological outcomes of chronic hepatitis C after successful interferon therapy. J Med Virol 2004; 74: 406-13.","DOI":"10.1002\/jmv.20190"},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB69","unstructured":"69.\u2002 Cacoub P , Renou C , Rosenthal E , et al. Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d'Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l'Hepatite C. Medicine 2000; 79: 47-56."},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB70","doi-asserted-by":"crossref","unstructured":"70.\u2002 El Serag HB , Hampel H , Yeh C , Rabeneck L. Extrahepatic manifestations of hepatitis C among United States male veterans. Hepatology 2002; 36: 1439-45.","DOI":"10.1002\/hep.1840360621"},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB71","doi-asserted-by":"crossref","unstructured":"71.\u2002 Gumber SC , Chopra S. Hepatitis C: a multifaceted disease. Review of extrahepatic manifestations. Ann Intern Med 1995; 123: 615-20.","DOI":"10.7326\/0003-4819-123-8-199510150-00008"},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB72","doi-asserted-by":"crossref","unstructured":"72.\u2002 Pawlotsky JM , Ben Yahia M , Andre C , et al. Immunological disorders in C virus chronic active hepatitis: a prospective case-control study. Hepatology 1994; 19: 841-8.","DOI":"10.1002\/hep.1840190407"},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB73","doi-asserted-by":"crossref","unstructured":"73.\u2002 Lunel F , Musset L , Cacoub P , et al. Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage. Gastroenterology 1994; 106: 1291-300.","DOI":"10.1016\/0016-5085(94)90022-1"},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB74","doi-asserted-by":"crossref","unstructured":"74.\u2002 Gisbert JP , Garcia-Buey L , Pajares JM , Moreno-Otero R. Prevalence of hepatitis C virus infection in B-cell non-Hodgkin's lymphoma: systematic review and meta-analysis. Gastroenterology 2003; 125: 1723-32.","DOI":"10.1053\/j.gastro.2003.09.025"},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB75","doi-asserted-by":"crossref","unstructured":"75.\u2002 Monti G , Pioltelli P , Saccardo F , et al. Incidence and characteristics of non-Hodgkin lymphomas in a multicenter case file of patients with hepatitis C virus-related symptomatic mixed cryoglobulinemias. Arch Intern Med 2005; 165: 101-5.","DOI":"10.1001\/archinte.165.1.101"},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB76","doi-asserted-by":"crossref","unstructured":"76.\u2002 Bronowicki JP , Bineau C , Feugier P , et al. Primary lymphoma of the liver: clinical-pathological features and relationship with HCV infection in French patients. Hepatology 2003; 37: 781-7.","DOI":"10.1053\/jhep.2003.50121"},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB77","doi-asserted-by":"crossref","unstructured":"77.\u2002 Kawamura Y , Ikeda K , Arase Y , et al. Viral elimination reduces incidence of malignant lymphoma in patients with hepatitis C. Am J Med 2007; 120: 1034-41.","DOI":"10.1016\/j.amjmed.2007.06.022"},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB78","doi-asserted-by":"crossref","unstructured":"78.\u2002 McGuire BM , Julian BA , Bynon JS Jr , et al. Brief communication: glomerulonephritis in patients with hepatitis C cirrhosis undergoing liver transplantation. Ann Intern Med 2006; 144: 735-41.","DOI":"10.7326\/0003-4819-144-10-200605160-00007"},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB79","doi-asserted-by":"crossref","unstructured":"79.\u2002 Fowell AJ , Sheron N , Rosenberg WM. Renal hepatitis C in the absence of detectable serum or hepatic virus. Liver Int 2008; 28: 889-91.","DOI":"10.1111\/j.1478-3231.2008.01672.x"},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB80","doi-asserted-by":"crossref","unstructured":"80.\u2002 Barril G , Castillo I , Arenas MD , et al. Occult hepatitis C virus infection among hemodialysis patients. J Am Soc Nephrol 2008; 19: 2288-92.","DOI":"10.1681\/ASN.2008030293"},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB81","doi-asserted-by":"crossref","unstructured":"81.\u2002 Casato M , Lilli D , Donato G , et al. Occult hepatitis C virus infection in type II mixed cryoglobulinaemia. J Viral Hepat 2003; 10: 455-9.","DOI":"10.1046\/j.1365-2893.2003.00462.x"},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB82","unstructured":"82.\u2002 Pardo M , Castillo I , Rodrigues-Inigo E , et al. Antiviral therapy in patients with occult HCV infection. Hepatology 2005; 42: 658A."},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB83","doi-asserted-by":"crossref","unstructured":"83.\u2002 MacParland SA , Pham TNQ , Guy CS , Michalak TI. Hepatitis C virus persisting after clinically apparent sustained virological response to antiviral therapy retains infectivity in vitro. Hepatology 2009; 49: 1431-41.","DOI":"10.1002\/hep.22802"},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB84","doi-asserted-by":"crossref","unstructured":"84.\u2002 Feinstone SM , Alter HJ , Dienes HP , et al. Non-A, non-B hepatitis in chimpanzees and marmosets. J Infect Dis 1981; 144: 588-98.","DOI":"10.1093\/infdis\/144.6.588"},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB85","doi-asserted-by":"crossref","unstructured":"85.\u2002 Katayama K , Kumagai J , Komiya Y , et al. Titration of hepatitis C virus in chimpanzees for determining the copy number required for transmission. Intervirology 2004; 47: 57-64.","DOI":"10.1159\/000076643"},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB86","doi-asserted-by":"crossref","unstructured":"86.\u2002 Castillo I , Bartolome J , Quiroga JA , et al. Hepatitis C virus infection in the family setting of patients with occult hepatitis C. J Med Virol 2009; 81: 1198-203.","DOI":"10.1002\/jmv.21483"},{"key":"10.1111\/j.1478-3231.2009.02193.x-BIB174","doi-asserted-by":"crossref","unstructured":"87.\u2002 Quiroga J , Casrtillo I , Llorente S , et al. Identification of serologically silent occult hepatitis C virus infection be detecting immunoglobulin G antibody to a dominant HCV core protein epitope. J Hepatol 2009; 50: 256-63.","DOI":"10.1016\/j.jhep.2008.08.021"}],"container-title":["Liver International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1478-3231.2009.02193.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1478-3231.2009.02193.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T11:55:56Z","timestamp":1685361356000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1478-3231.2009.02193.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":87,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,4]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1478-3231.2009.02193.x","relation":{},"ISSN":["1478-3223","1478-3231"],"issn-type":[{"value":"1478-3223","type":"print"},{"value":"1478-3231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}